Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia

This study is ongoing, but not recruiting participants.

Study NCT00034528 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: April 30, 2002 Last Updated: September 26, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Beta-Thalassemia

More general conditions related to this trial

Interventions listed in this trial

Busulfex
Fludarabine
FK506
Prednisone

More general drug interventions related to this trial

Sponsors listed in this trial